Industry
Satellite Symposia
SORT BY
Tuesday March 22 (12:30 - 13:30 CET)
ADVOS therapy - Integrated 4-in-1 Extracorporeal Multi-Organ Support (ECOS)
400 Hall
Tuesday March 22
(12:30- 13:30 CET)
Updates in Haemodynamic Management of Septic Patients
Copper Hall
Tuesday March 22
(12:30- 13:30 CET)
Fluid management in critically ill patients
100 Hall
Tuesday March 22
(12:30- 13:30 CET)
Moving from empirical therapy to early documented antibiotic therapy in ICU patient
The Arc Room
Tuesday March 22
(12:30- 13:30 CET)
Patient safety in the ICU: How AI innovation helps prevent hemodynamic instability
Silver Hall
Tuesday March 22
(12:30- 13:30 CET)
Learnings from the EuroPN study
Tent
Tuesday March 22
(12:30- 13:30 CET)
Challenging cases in the treatment of ICU gram-negative pneumonia
Studio Room
Tuesday March 22
(12:30- 13:30 CET)
Refractory distributive shock: coupling treatment advances with identifying the most appropriate patients
Salle M (Bozar)
Tuesday March 22
(12:30- 13:30 CET)
Managing the risks and challenges of IMD in the ICU
Gold Hall
Tuesday March 22
(12:30- 13:30 CET)
Wednesday March 23 (12:30 - 13:30 CET)
New perspectives on extracorporeal organ support
100 Hall
Wednesday March 23
(12:30- 13:30 CET)
Developing a key to SEPSIS: Clinical performance of MDW
Salle M (Bozar)
Wednesday March 23
(12:30- 13:30 CET)
SEPSIS management & antimicrobial stewerdship
The Arc Room
Wednesday March 23
(12:30- 13:30 CET)
Therapeutic benefits by blood purification – Using COVID-19 as example
Silver Hall
Wednesday March 23
(12:30- 13:30 CET)
Fluid and Nutrition Strategy in the ICU
400 Hall
Wednesday March 23
(12:30- 13:30 CET)
How much is required? - Current guidance on individualized bleeding management in trauma, surgery and ICU
Tent
Wednesday March 23
(12:30- 13:30 CET)
The art of clinical decision-making in the ICU: challenging case studies of MDR Gram-negative infections
Gold Hall
Wednesday March 23
(12:30- 13:30 CET)
aTTP in ICU - An emergency disease requiring early diagnosis and rapid on-set of treatment
Studio Room
Wednesday March 23
(12:30- 13:30 CET)
Thursday March 24 (12:30 - 13:30 CET)
Clinical relevance of IgM-enriched immunoglobulins in COVID-19
Salle M (Bozar)
Thursday March 24
(12:30- 13:30 CET)
Hemoadsorption with CytoSorb as part of an individualized therapy in critically-ill patients
Copper Hall
Thursday March 24
(12:30- 13:30 CET)
Every Hour Counts – Timely Initiation of Anti-infective Treatment in ICU Patients
Silver Hall
Thursday March 24
(12:30- 13:30 CET)
A Comprehensive Platform for Optimizing Oxygen Delivery to match Metabolic Needs of Vital Organs
Tent
Thursday March 24
(12:30- 13:30 CET)
Streamlining the management of CAP – Focus on the ICU
Gold Hall
Thursday March 24
(12:30- 13:30 CET)
Introducing inhaled sedation to intensive care
400 Hall
Thursday March 24
(12:30- 13:30 CET)
Friday March 25 (12:30 - 13:30 CET)
New perspectives on Transient Mechanical Circulatory Support in Cardiogenic Shock Patient
Copper Hall
Friday March 25
(12:30- 13:30 CET)
Mechanical Ventilation De-escalation in the ICU: How to Improve the Weaning Process?
Silver Hall
Friday March 25
(12:30- 13:30 CET)
Are Fibrinogen Sources all the same?
100 Hall
Friday March 25
(12:30- 13:30 CET)
Protein requirements in ICU patients: New clinical trials addressing some unknowns
400 Hall
Friday March 25
(12:30- 13:30 CET)
New perspectives on Transient Mechanical Circulatory Support in Cardiogenic Shock Patient
Copper Hall
Friday March 25
(12:30- 13:30 CET)
ADVOS therapy - Integrated 4-in-1 Extracorporeal Multi-Organ Support (ECOS)
400 Hall
Tuesday March 22
(12:30- 13:30 CET)
Updates in Haemodynamic Management of Septic Patients
Copper Hall
Tuesday March 22
(12:30- 13:30 CET)
Fluid management in critically ill patients
100 Hall
Tuesday March 22
(12:30- 13:30 CET)
New perspectives on extracorporeal organ support
100 Hall
Wednesday March 23
(12:30- 13:30 CET)
Developing a key to SEPSIS: Clinical performance of MDW
Salle M (Bozar)
Wednesday March 23
(12:30- 13:30 CET)
Moving from empirical therapy to early documented antibiotic therapy in ICU patient
The Arc Room
Tuesday March 22
(12:30- 13:30 CET)
SEPSIS management & antimicrobial stewerdship
The Arc Room
Wednesday March 23
(12:30- 13:30 CET)
Clinical relevance of IgM-enriched immunoglobulins in COVID-19
Salle M (Bozar)
Thursday March 24
(12:30- 13:30 CET)
Hemoadsorption with CytoSorb as part of an individualized therapy in critically-ill patients
Copper Hall
Thursday March 24
(12:30- 13:30 CET)
Patient safety in the ICU: How AI innovation helps prevent hemodynamic instability
Silver Hall
Tuesday March 22
(12:30- 13:30 CET)
Learnings from the EuroPN study
Tent
Tuesday March 22
(12:30- 13:30 CET)
Therapeutic benefits by blood purification – Using COVID-19 as example
Silver Hall
Wednesday March 23
(12:30- 13:30 CET)
Mechanical Ventilation De-escalation in the ICU: How to Improve the Weaning Process?
Silver Hall
Friday March 25
(12:30- 13:30 CET)
Every Hour Counts – Timely Initiation of Anti-infective Treatment in ICU Patients
Silver Hall
Thursday March 24
(12:30- 13:30 CET)
Are Fibrinogen Sources all the same?
100 Hall
Friday March 25
(12:30- 13:30 CET)
A Comprehensive Platform for Optimizing Oxygen Delivery to match Metabolic Needs of Vital Organs
Tent
Thursday March 24
(12:30- 13:30 CET)
Challenging cases in the treatment of ICU gram-negative pneumonia
Studio Room
Tuesday March 22
(12:30- 13:30 CET)
Fluid and Nutrition Strategy in the ICU
400 Hall
Wednesday March 23
(12:30- 13:30 CET)
Protein requirements in ICU patients: New clinical trials addressing some unknowns
400 Hall
Friday March 25
(12:30- 13:30 CET)
How much is required? - Current guidance on individualized bleeding management in trauma, surgery and ICU
Tent
Wednesday March 23
(12:30- 13:30 CET)
Refractory distributive shock: coupling treatment advances with identifying the most appropriate patients
Salle M (Bozar)
Tuesday March 22
(12:30- 13:30 CET)
Managing the risks and challenges of IMD in the ICU
Gold Hall
Tuesday March 22
(12:30- 13:30 CET)
The art of clinical decision-making in the ICU: challenging case studies of MDR Gram-negative infections
Gold Hall
Wednesday March 23
(12:30- 13:30 CET)
Streamlining the management of CAP – Focus on the ICU
Gold Hall
Thursday March 24
(12:30- 13:30 CET)
aTTP in ICU - An emergency disease requiring early diagnosis and rapid on-set of treatment
Studio Room
Wednesday March 23
(12:30- 13:30 CET)
Introducing inhaled sedation to intensive care
400 Hall
Thursday March 24
(12:30- 13:30 CET)
100 Hall
Fluid management in critically ill patients
Tuesday March 22
(12:30- 13:30 CET)
New perspectives on extracorporeal organ support
Wednesday March 23
(12:30- 13:30 CET)
Are Fibrinogen Sources all the same?
Friday March 25
(12:30- 13:30 CET)
400 Hall
ADVOS therapy - Integrated 4-in-1 Extracorporeal Multi-Organ Support (ECOS)
Tuesday March 22
(12:30- 13:30 CET)
Fluid and Nutrition Strategy in the ICU
Wednesday March 23
(12:30- 13:30 CET)
Introducing inhaled sedation to intensive care
Thursday March 24
(12:30- 13:30 CET)
Protein requirements in ICU patients: New clinical trials addressing some unknowns
Friday March 25
(12:30- 13:30 CET)
Copper Hall
Updates in Haemodynamic Management of Septic Patients
Tuesday March 22
(12:30- 13:30 CET)
Hemoadsorption with CytoSorb as part of an individualized therapy in critically-ill patients
Thursday March 24
(12:30- 13:30 CET)
New perspectives on Transient Mechanical Circulatory Support in Cardiogenic Shock Patient
Friday March 25
(12:30- 13:30 CET)
Gold Hall
Managing the risks and challenges of IMD in the ICU
Tuesday March 22
(12:30- 13:30 CET)
The art of clinical decision-making in the ICU: challenging case studies of MDR Gram-negative infections
Wednesday March 23
(12:30- 13:30 CET)
Streamlining the management of CAP – Focus on the ICU
Thursday March 24
(12:30- 13:30 CET)
Salle M (Bozar)
Refractory distributive shock: coupling treatment advances with identifying the most appropriate patients
Tuesday March 22
(12:30- 13:30 CET)
Developing a key to SEPSIS: Clinical performance of MDW
Wednesday March 23
(12:30- 13:30 CET)
Clinical relevance of IgM-enriched immunoglobulins in COVID-19
Thursday March 24
(12:30- 13:30 CET)
Silver Hall
Patient safety in the ICU: How AI innovation helps prevent hemodynamic instability
Tuesday March 22
(12:30- 13:30 CET)
Therapeutic benefits by blood purification – Using COVID-19 as example
Wednesday March 23
(12:30- 13:30 CET)
Every Hour Counts – Timely Initiation of Anti-infective Treatment in ICU Patients
Thursday March 24
(12:30- 13:30 CET)
Mechanical Ventilation De-escalation in the ICU: How to Improve the Weaning Process?
Friday March 25
(12:30- 13:30 CET)
Studio Room
Challenging cases in the treatment of ICU gram-negative pneumonia
Tuesday March 22
(12:30- 13:30 CET)
aTTP in ICU - An emergency disease requiring early diagnosis and rapid on-set of treatment
Wednesday March 23
(12:30- 13:30 CET)
Tent
Learnings from the EuroPN study
Tuesday March 22
(12:30- 13:30 CET)
How much is required? - Current guidance on individualized bleeding management in trauma, surgery and ICU
Wednesday March 23
(12:30- 13:30 CET)
A Comprehensive Platform for Optimizing Oxygen Delivery to match Metabolic Needs of Vital Organs
Thursday March 24
(12:30- 13:30 CET)
The Arc Room
Moving from empirical therapy to early documented antibiotic therapy in ICU patient
Tuesday March 22
(12:30- 13:30 CET)
SEPSIS management & antimicrobial stewerdship
Wednesday March 23
(12:30- 13:30 CET)